-+ 0.00%
-+ 0.00%
-+ 0.00%

Halozyme plans USD 1.05 billion convertible senior notes offering due 2033

PUBT·09/16/2026 20:31:36
Listen to the news
Halozyme plans USD 1.05 billion convertible senior notes offering due 2033
  • Halozyme announced a proposed offering of USD 1.05 billion convertible senior notes due 2033.
  • Deal includes a 13-day option for initial purchasers to buy up to an additional USD 150 million of notes.
  • Proceeds expected to fund capped call transactions, reducing dilution tied to conversions.
  • Part of proceeds earmarked to repurchase outstanding 0.25% convertible senior notes due 2027, 1% convertible senior notes due 2028.
  • Notes expected to mature Oct. 1, 2033; interest terms set at pricing.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Halozyme Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202609161630PR_NEWS_USPR_____LA49849) on September 16, 2026, and is solely responsible for the information contained therein.